Novel Glycosylation Technologies for the Development of Biosimilars and Biobetters
Glycosylation has moved centre-stage in the development of
biopharmaceutical products and, in the near future, it can be expected
that the therapeutic and commercial success of many products will
depend on correct glycosylation patterns.
By Hans Baumeister and Steffen Goletz at Glycotope (December 2009)
Keywords: glycosylation, biosimilars, biobetters, therapeutic, baumeister, goletz, glycotope